Literature DB >> 10350554

Oxidized lipoproteins increase reactive oxygen species formation in microglia and astrocyte cell lines.

J N Keller1, K B Hanni, S P Gabbita, V Friebe, M P Mattson, M S Kindy.   

Abstract

Lipoproteins exist in the central nervous system and surrounding vasculature possibly mediating effects upon cells in the brain during times of oxidative stress or compromised blood-brain barrier. The focus of the present study was to determine the effect of unmodified and oxidatively modified lipoproteins on astrocytes and microglia. Application of oxidized low-density lipoprotein resulted in an increase in DCF fluorescence, which was inhibited by pretreatment with antioxidants, consistent with the formation of reactive oxygen species (ROS). Low-density at concentrations below 20 microg/ml likewise increased ROS formation. Because ROS are associated with numerous astrocyte and microglia activities including proliferation, activation, and cytokine production it is possible that lipoproteins may mediate such effects on glial cells in the central nervous system. Copyright 1999 Elsevier Science B.V.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10350554     DOI: 10.1016/s0006-8993(99)01272-x

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  15 in total

1.  Serum Amyloid A-Mediated Inflammasome Activation of Microglial Cells in Cerebral Ischemia.

Authors:  Jin Yu; Hong Zhu; Saeid Taheri; William Mondy; Leonardo Bonilha; Gayenell S Magwood; Daniel Lackland; Robert J Adams; Mark S Kindy
Journal:  J Neurosci       Date:  2019-10-14       Impact factor: 6.167

2.  Changes in cholesterol metabolism are associated with PS1 and PS2 gene regulation in SK-N-BE.

Authors:  A Crestini; M Napolitano; P Piscopo; A Confaloni; E Bravo
Journal:  J Mol Neurosci       Date:  2006       Impact factor: 3.444

Review 3.  Reimagining Alzheimer's disease--an age-based hypothesis.

Authors:  Karl Herrup
Journal:  J Neurosci       Date:  2010-12-15       Impact factor: 6.167

4.  Accumulation of protein carbonyls within cerebellar astrocytes in murine experimental autoimmune encephalomyelitis.

Authors:  Jianzheng Zheng; Oscar A Bizzozero
Journal:  J Neurosci Res       Date:  2010-11-15       Impact factor: 4.164

5.  Microglial activation and dopaminergic cell injury: an in vitro model relevant to Parkinson's disease.

Authors:  W Le; D Rowe; W Xie; I Ortiz; Y He; S H Appel
Journal:  J Neurosci       Date:  2001-11-01       Impact factor: 6.167

6.  Lipoproteins obtained from anorexia nervosa patients induce higher oxidative stress in U373MG astrocytes through nitric oxide production.

Authors:  Arianna Vignini; Paola Canibus; Laura Nanetti; Giorgio Montecchiani; Emanuela Faloia; Anna Maria Cester; Marco Boscaro; Laura Mazzanti
Journal:  Neuromolecular Med       Date:  2007-09-15       Impact factor: 3.843

7.  Activation of PERK kinase in neural cells by proteasome inhibitor treatment.

Authors:  Le Zhang; Philip J Ebenezer; Kalavathi Dasuri; Annadora J Bruce-Keller; Sun Ok Fernandez-Kim; Ying Liu; Jeffrey N Keller
Journal:  J Neurochem       Date:  2009-10-24       Impact factor: 5.372

8.  Reactive oxygen species up-regulate CD11b in microglia via nitric oxide: Implications for neurodegenerative diseases.

Authors:  Avik Roy; Arundhati Jana; Kavitha Yatish; Matthew B Freidt; Yiu K Fung; Jeffrey A Martinson; Kalipada Pahan
Journal:  Free Radic Biol Med       Date:  2008-06-06       Impact factor: 7.376

9.  Oxidized lipoproteins, beta amyloid peptides and Alzheimer's disease.

Authors:  A Y Sun; B Draczynska-Lusiak; G Y Sun
Journal:  Neurotox Res       Date:  2001-04       Impact factor: 3.911

10.  Differential regulation of inducible nitric oxide synthase and cyclooxygenase-2 expression by superoxide dismutase in lipopolysaccharide stimulated RAW 264.7 cells.

Authors:  Ji Ae Lee; Ha Yong Song; Sung Mi Ju; Su Jin Lee; Hyung Joo Kwon; Won Sik Eum; Sang Ho Jang; Soo Young Choi; Jin Seu Park
Journal:  Exp Mol Med       Date:  2009-09-30       Impact factor: 8.718

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.